FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Updates eMDR System Enhancements

FDA updates a Web page with enhancements to the CDRH electronic medical device reporting system.

latest-news-card-1
Medical Devices

MDIC Somatic Reference Samples Initiative

The Medical Device Innovation Consortium launches an initiative to improve the accuracy of next-generation sequencing-based cancer diagnostics.

latest-news-card-1
FDA General

Califf on FDA and the Clinical Community

FDA commissioner Robert Califf discusses the agencys future actions in key priorities including evidence generation and accelerating progress against ...

latest-news-card-1
Biologics

Moderna Seeks EUA for Omicron-targeting Booster

Moderna submits an EUA for a BA.4/BA.5 Omicron-targeting bivalent booster vaccine that could be available early next month.

latest-news-card-1
Medical Devices

Optical Lens Maker Pays $16.4 Million Over False Claims

Essilor International (Dallas, TX) agrees to pay $16.4 million to resolve allegations that it violated the False Claims Act by paying eye care provide...

latest-news-card-1
Federal Register

Panel to Vote on Ipsen NDA for Palovarotene

Federal Register notice: FDA announces a 10/31 Endocrinologic and Metabolic Drugs Advisory Committee meeting.

latest-news-card-1
Federal Register

OMB Approves 11 FDA Info Collections

Federal Register notice: FDA posts a notification that OMB has approved 11 recent information collections.

latest-news-card-1
Human Drugs

CDER to Discuss Quality Management Maturity at Meeting

CDER plans to review and discuss its proposed Quality Management Maturity program at an 11/2 advisory committee meeting.

latest-news-card-1
Medical Devices

Alert on Autoinjectors with Multiple Sclerosis Drugs

FDA issues a safety alert on autoinjector devices that are optional for use with multiple sclerosis therapy glatiramer acetate injection drug products...

latest-news-card-1
Human Drugs

FDA Hold on Pharvaris Hereditary Angioedema Therapy

FDA issues Pharvaris a clinical hold on two clinical trials of its PHA121, an oral bradykini B2-receptor antagonist for treating and preventing heredi...